Get the Stockscreener App
36.39
2.10%
-0.78
After Hours:
36.39
Phibro Animal Health Corp stock is traded at $36.39, with a volume of 193.36K.
It is down -2.10% in the last 24 hours and down -11.63% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$37.17
Open:
$37.29
24h Volume:
193.36K
Relative Volume:
0.63
Market Cap:
$741.18M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
98.35
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-5.04%
1M Performance:
-11.63%
6M Performance:
+105.36%
1Y Performance:
+58.98%
1-Day Range:
$35.81
$37.40
1-Week Range:
$35.81
$38.77
52-Week Range:
$16.16
$41.57
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
36.39 | 1.51B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Can Phibro Animal Health Corporation (PB8) stock double in coming yearsJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
State of Alaska Department of Revenue Buys 859 Shares of Phibro Animal Health Corporation $PAHC - Defense World
PAHC Secures Licensing Agreement for Canine Periodontal Health - GuruFocus
Phibro Animal Health licenses novel canine periodontal therapy - Investing.com
Phibro Animal Health announces licensing pact with Lighthouse Pharmaceuticals - TipRanks
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs - FinancialContent
Phibro Animal Health Corporation stock trend outlook and recovery pathMarket Trend Report & Capital Protection Trade Alerts - newser.com
Phibro Animal Health Corporation : New Animal Growth Phase - MarketScreener
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Public Employees Retirement System of Ohio Sells 4,480 Shares of Phibro Animal Health Corporation $PAHC - Defense World
Published on: 2025-10-06 00:49:27 - newser.com
Can Phibro Animal Health Corporation (PB8) stock expand revenue streams2025 Market WrapUp & Daily Price Action Insights - newser.com
What’s next for Phibro Animal Health Corporation stock priceJuly 2025 Trends & Community Verified Trade Signals - newser.com
Is Phibro Animal Health Corporation a good long term investmentMarket Entry Points & Affordable Investment Strategies - earlytimes.in
Will Phibro Animal Health Corporation stock deliver strong dividend growthAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Reversal indicators forming on Phibro Animal Health Corporation stockMarket Trend Report & Reliable Intraday Trade Plans - newser.com
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost - Insider Monkey
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
3 Companies That May Be Priced Below Their Estimated Value - Yahoo Finance
Will Phibro Animal Health Corporation (PB8) stock hit analyst forecastsJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Will Phibro Animal Health Corporation stock outperform tech sector in 2025Weekly Trend Summary & Consistent Growth Equity Picks - newser.com
Can Phibro Animal Health Corporation (PB8) stock sustain institutional flowsQuarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
How hedge fund analytics apply to Phibro Animal Health Corporation stockWatch List & Technical Buy Zone Confirmation - newser.com
Short interest data insights for Phibro Animal Health Corporation2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Q3 EPS Estimate for Phibro Animal Health Boosted by Analyst - Defense World
Why Is Phibro (PAHC) Down 1.1% Since Last Earnings Report? - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Published on: 2025-09-26 06:40:38 - newser.com
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It? - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Visual analytics tools that track Phibro Animal Health Corporation performancePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
How to manage a losing position in Phibro Animal Health CorporationBuy Signal & Accurate Entry/Exit Alerts - newser.com
Bendheim Jack, director at Phibro, sells $282k in shares By Investing.com - Investing.com Canada
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 7,022 Shares of Stock - MarketBeat
Bendheim Jack, director at Phibro, sells $282k in shares - Investing.com
Analyzing Phibro Animal Health Corporation with multi timeframe chartsWall Street Watch & Weekly Top Stock Performers List - newser.com
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock - Yahoo Finance
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phibro Animal Health Corp Stock (PAHC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
Sep 18 '25 |
Sale |
40.26 |
7,022 |
282,732 |
31,338 |
| BENDHEIM JACK | President and CEO |
Sep 09 '25 |
Sale |
40.33 |
14,080 |
567,841 |
45,400 |
| BENDHEIM JACK | President and CEO |
Sep 10 '25 |
Sale |
41.29 |
3,520 |
145,336 |
41,880 |
| BENDHEIM JACK | President and CEO |
Sep 11 '25 |
Sale |
40.95 |
3,520 |
144,137 |
38,360 |
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):